PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
5.23%
Revenue growth above 1.5x ON's 2.45%. David Dodd would confirm if the firm has a unique advantage driving sales higher.
5.71%
Gross profit growth 1.25-1.5x ON's 4.74%. Bruce Berkowitz would see if strategic sourcing or brand premium explains outperformance.
0.51%
Positive EBIT growth while ON is negative. John Neff might see a substantial edge in operational management.
6.95%
Positive operating income growth while ON is negative. John Neff might view this as a competitive edge in operations.
3.85%
Net income growth above 1.5x ON's 1.01%. David Dodd would check if a unique moat or cost structure secures superior bottom-line gains.
3.83%
EPS growth of 3.83% while ON is zero. Bruce Berkowitz would see if minimal gains can accelerate over time.
3.89%
Positive diluted EPS growth while ON is negative. John Neff might view this as a strong relative advantage in controlling dilution.
0.33%
Share count expansion well above ON's 0.51%. Michael Burry would question if management is raising capital unnecessarily or is over-incentivizing employees with stock.
0.32%
Diluted share reduction more than 1.5x ON's 3.20%. David Dodd would validate if the company is aggressively retiring shares or limiting option exercises.
-0.01%
Dividend reduction while ON stands at 0.00%. Joel Greenblatt would question the firm’s cash flow stability or capital allocation decisions.
-12.94%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
-19.39%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
60.04%
10Y revenue/share CAGR at 50-75% of ON's 81.72%. Martin Whitman would question if the firm’s offerings lag behind the competitor.
55.67%
5Y revenue/share CAGR at 50-75% of ON's 80.96%. Martin Whitman would worry about a lagging mid-term growth trajectory.
20.69%
3Y revenue/share CAGR above 1.5x ON's 10.81%. David Dodd would confirm if there's an emerging competitive moat driving recent gains.
353.80%
10Y OCF/share CAGR above 1.5x ON's 85.75%. David Dodd would check if a superior product mix or cost edge drives this outperformance.
269.23%
5Y OCF/share CAGR above 1.5x ON's 89.80%. David Dodd would confirm if the firm has better cost structures or brand premium boosting mid-term cash flow.
77.37%
Positive 3Y OCF/share CAGR while ON is negative. John Neff might see a big short-term edge in operational efficiency.
233.16%
Net income/share CAGR above 1.5x ON's 28.33% over 10 years. David Dodd would confirm if brand, IP, or scale secure this persistent advantage.
169.17%
5Y net income/share CAGR 1.25-1.5x ON's 149.24%. Bruce Berkowitz would check if a better product mix or cost discipline explains the gap.
36.82%
Positive short-term CAGR while ON is negative. John Neff would see a clear advantage in near-term profit trajectory.
21.69%
Below 50% of ON's 160.62%. Michael Burry would suspect poor capital allocation or persistent net losses eroding long-term equity build-up.
13.46%
Below 50% of ON's 119.02%. Michael Burry sees a substantially weaker mid-term book value expansion strategy in place.
1.85%
Below 50% of ON's 27.69%. Michael Burry suspects a serious short-term disadvantage in building book value.
677.64%
Dividend/share CAGR of 677.64% while ON is zero. Bruce Berkowitz sees a slight advantage in stepping up payouts steadily.
167.94%
Dividend/share CAGR of 167.94% while ON is zero. Bruce Berkowitz sees a minor advantage in stepping up distributions, even modestly.
64.02%
3Y dividend/share CAGR of 64.02% while ON is zero. Bruce Berkowitz sees a minor positive difference that could attract dividend-focused investors.
12.02%
AR growth well above ON's 1.12%. Michael Burry fears inflated revenue or higher default risk in the near future.
-3.32%
Inventory is declining while ON stands at 3.52%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
1.49%
Positive asset growth while ON is shrinking. John Neff sees potential for us to outgrow the competitor if returns are solid.
10.30%
BV/share growth above 1.5x ON's 2.05%. David Dodd confirms if consistent profit retention or fewer write-downs yield faster equity creation.
-12.21%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
-0.52%
Our R&D shrinks while ON invests at 8.70%. Joel Greenblatt checks if we risk falling behind a competitor’s new product pipeline.
6.78%
SG&A growth well above ON's 13.42%. Michael Burry sees potential margin erosion unless it translates into higher sales or brand equity.